Literature DB >> 28370346

Medication adherence and rejection rates in older vs younger adult liver transplant recipients.

Emily A Leven1, Rachel Annunziato2, Jacqueline Helcer2, Sarah R Lieber3, Christopher S Knight2, Catherine Wlodarkiewicz4, Rainier P Soriano5, Sander S Florman6, Thomas D Schiano7, Eyal Shemesh8.   

Abstract

A growing number of older adults are undergoing liver transplantation (LT) in the United States. In some settings, it is thought that adherence declines with age. This retrospective study examined adherence and clinical outcomes in older vs younger adult LT recipients. Medical records of adult LT recipients from 2009 to 2012 from a single urban center were reviewed. The medication level variability index (MLVI) was the predefined primary outcome, with nonadherence defined as MLVI >2.5. The secondary outcome was incidence of rejection. Outcomes were evaluated starting 1 year post-LT until 2015. A total of 42 of 248 patients were ≥65 at transplant. Older adults had significantly better adherence than younger ones (65%≥65 were adherent vs 42% younger adults; chi-square two-tailed P=.02). Survival analyses of rejection between age groups censored by time since transplant showed no difference among the four age groups (χ2 =0.84, P=.84). Older age was not found to be a risk factor for reduced adherence or graft rejection in patients surviving at least 1 year post-LT.
© 2017 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  biomarkers; graft rejection; medication adherence

Mesh:

Substances:

Year:  2017        PMID: 28370346      PMCID: PMC5485915          DOI: 10.1111/ctr.12981

Source DB:  PubMed          Journal:  Clin Transplant        ISSN: 0902-0063            Impact factor:   2.863


  32 in total

Review 1.  Medication non-adherence among older adults: a review of strategies and interventions for improvement.

Authors:  Elizabeth A Schlenk; Jacqueline Dunbar-Jacob; Sandra Engberg
Journal:  J Gerontol Nurs       Date:  2004-07       Impact factor: 1.254

Review 2.  Optimizing medication adherence: an ongoing opportunity to improve outcomes after kidney transplantation.

Authors:  Mary B Prendergast; Robert S Gaston
Journal:  Clin J Am Soc Nephrol       Date:  2010-05-06       Impact factor: 8.237

Review 3.  Medication adherence and persistence: a comprehensive review.

Authors:  Kem P Krueger; Bruce A Berger; Bill Felkey
Journal:  Adv Ther       Date:  2005 Jul-Aug       Impact factor: 3.845

4.  Age and liver transplantation: a report of the Liver Transplantation Database.

Authors:  R K Zetterman; S H Belle; J H Hoofnagle; S Lawlor; Y Wei; J Everhart; R H Wiesner; J R Lake
Journal:  Transplantation       Date:  1998-08-27       Impact factor: 4.939

Review 5.  A systematic review of barriers to medication adherence in the elderly: looking beyond cost and regimen complexity.

Authors:  Walid F Gellad; Jerry L Grenard; Zachary A Marcum
Journal:  Am J Geriatr Pharmacother       Date:  2011-02

6.  Outcomes after liver transplant in patients aged 70 years or older compared with those younger than 60 years.

Authors:  Javier F Aduen; Bangarulingam Sujay; Rolland C Dickson; Michael G Heckman; Winston R Hewitt; Wolf H Stapelfeldt; Jeffrey L Steers; Denise M Harnois; David J Kramer
Journal:  Mayo Clin Proc       Date:  2009-11       Impact factor: 7.616

7.  Compliance and noncompliance in patients with a functioning renal transplant: a multicenter study.

Authors:  S Greenstein; B Siegal
Journal:  Transplantation       Date:  1998-12-27       Impact factor: 4.939

8.  Liver transplantation in patients over 60 and 65 years: an evaluation of long-term outcomes and survival.

Authors:  Timothy J S Cross; Charalambos G Antoniades; Paolo Muiesan; Thawab Al-Chalabi; Varuna Aluvihare; Kosh Agarwal; Bernard C Portmann; Mohammed Rela; Nigel D Heaton; John G O'Grady; Michael A Heneghan
Journal:  Liver Transpl       Date:  2007-10       Impact factor: 5.799

9.  Describing the evolution of medication nonadherence from pretransplant until 3 years post-transplant and determining pretransplant medication nonadherence as risk factor for post-transplant nonadherence to immunosuppressives: the Swiss Transplant Cohort Study.

Authors:  Sabina De Geest; Hanna Burkhalter; Laura Bogert; Lut Berben; Tracy R Glass; Kris Denhaerynck
Journal:  Transpl Int       Date:  2014-04-29       Impact factor: 3.782

10.  Our experience in liver transplantation in patients over 65 yr of age.

Authors:  Itxarone Bilbao; Cristina Dopazo; Jose Luis Lazaro; Luis Castells; Alfredo Escartin; Iñigo Lopez; Gonzalo Sapisochin; Joaquin Balsells; Carlos Margarit
Journal:  Clin Transplant       Date:  2008 Jan-Feb       Impact factor: 2.863

View more
  5 in total

1.  Medication non-adherence among liver transplant recipients.

Authors:  Lauren S Jones; Marina Serper
Journal:  Curr Hepatol Rep       Date:  2020-10-24

2.  Validation of an Arabic Version of the Self-Efficacy for Appropriate Medication Use Scale.

Authors:  Hawazin Alhazzani; Ghaida AlAmmari; Nouf AlRajhi; Ibrahim Sales; Amr Jamal; Turky H Almigbal; Mohammed A Batais; Yousif A Asiri; Yazed AlRuthia
Journal:  Int J Environ Res Public Health       Date:  2021-11-15       Impact factor: 3.390

3.  The Impact of Socio-Demographic Factors on the Functioning of Liver Transplant Patients.

Authors:  Agnieszka Kisielska; Daria Schneider-Matyka; Kamila Rachubińska; Przemysław Ustanowski; Anita Rybicka; Elżbieta Grochans
Journal:  Int J Environ Res Public Health       Date:  2022-04-01       Impact factor: 3.390

4.  Thirty-day readmission rates, trends and its impact on liver transplantation recipients: a national analysis.

Authors:  Khalid Mumtaz; Jannel Lee-Allen; Kyle Porter; Sean Kelly; James Hanje; Lanla F Conteh; Anthony J Michaels; Ashraf El-Hinnawi; Ken Washburn; Sylvester M Black; Marwan S Abougergi
Journal:  Sci Rep       Date:  2020-11-06       Impact factor: 4.379

5.  Efficacy of Adherence-Enhancing Interventions for Immunosuppressive Therapy in Solid Organ Transplant Recipients: A Systematic Review and Meta-Analysis Based on Randomized Controlled Trials.

Authors:  Yue-Xian Shi; Chun-Xia Liu; Fei Liu; Hai-Ming Zhang; Ming-Ming Yu; Yin-Hui Jin; Shao-Mei Shang; Ying-Xin Fu
Journal:  Front Pharmacol       Date:  2020-10-20       Impact factor: 5.810

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.